ArticleDiabetology & metabolic syndrome2024
Impact of canagliflozin combined with metformin therapy on reducing cardiovascular risk in type 2 diabetes patients.
Xiaoyu Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it